Emerging Epidemics in Transplant: Histoplasmosis, Blastomycosis, and Paracoccidioidomycosis
暂无分享,去创建一个
[1] A. Colombo,et al. Paracoccidioidomycosis in Immunocompromised Patients: A Literature Review , 2018, Journal of fungi.
[2] R. Dittus,et al. Mapping Histoplasma capsulatum Exposure, United States , 2018, Emerging infectious diseases.
[3] D. van Duin,et al. Endemic Mycoses in Solid Organ Transplant Recipients. , 2018, Infectious disease clinics of North America.
[4] D. Kontoyiannis,et al. Advances in the diagnosis and treatment of fungal infections of the CNS , 2018, The Lancet Neurology.
[5] P. Muñoz,et al. Endemic Fungal Infection Recommendations for Solid-Organ Transplant Recipients and Donors. , 2018, Transplantation.
[6] D. Denning,et al. Histoplasmosis in Africa: An emerging or a neglected disease? , 2018, PLoS neglected tropical diseases.
[7] S. Deresinski,et al. Histoplasmosis in transplant recipients , 2017, Clinical transplantation.
[8] F. Queiroz-Telles,et al. Brazilian guidelines for the clinical management of paracoccidioidomycosis. , 2017, Revista da Sociedade Brasileira de Medicina Tropical.
[9] C. Kauffman,et al. Pulmonary Blastomycosis in a Hematopoietic Cell Transplant Recipient , 2016 .
[10] D. Engelthaler,et al. Worldwide Phylogenetic Distributions and Population Dynamics of the Genus Histoplasma , 2016, PLoS neglected tropical diseases.
[11] J. Perfect,et al. Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] T. Toyotome,et al. Detection of Histoplasma capsulatum from clinical specimens by cycling probe-based real-time PCR and nested real-time PCR. , 2016, Medical mycology.
[13] R. Mody,et al. Epidemiology of Histoplasmosis Outbreaks, United States, 1938–2013 , 2016, Emerging infectious diseases.
[14] J. P. Woods. Revisiting old friends: Developments in understanding Histoplasma capsulatum pathogenesis , 2016, Journal of Microbiology.
[15] Jeannina A Smith,et al. New Developments in Blastomycosis , 2015, Seminars in Respiratory and Critical Care Medicine.
[16] T. Novicki,et al. Blastomyces Antigen Detection for Diagnosis and Management of Blastomycosis , 2015, Journal of Clinical Microbiology.
[17] R. Martinez. EPIDEMIOLOGY OF PARACOCCIDIOIDOMYCOSIS , 2015, Revista do Instituto de Medicina Tropical de Sao Paulo.
[18] C. Kauffman,et al. Histoplasmosis and Blastomycosis in Solid Organ Transplant Recipients , 2015, Journal of fungi.
[19] G. Sarosi,et al. Histoplasmosis Infections Worldwide: Thinking Outside of the Ohio River Valley , 2015, Current Tropical Medicine Reports.
[20] E. Anaissie,et al. Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant‐Associated Infection Surveillance Network (TRANSNET) , 2014, Transplant infectious disease : an official journal of the Transplantation Society.
[21] B. Wanke,et al. Itraconazole vs. trimethoprim-sulfamethoxazole: A comparative cohort study of 200 patients with paracoccidioidomycosis. , 2014, Medical mycology.
[22] R. Mendes,et al. Comparison between Itraconazole and Cotrimoxazole in the Treatment of Paracoccidiodomycosis , 2014, PLoS neglected tropical diseases.
[23] J. Baddley,et al. Histoplasmosis after solid organ transplant. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] E. Blume,et al. Allograft-Transmitted Histoplasma capsulatum Infection in a Solid Organ Transplant Recipient. , 2013, Journal of the Pediatric Infectious Diseases Society.
[25] T. Umeyama,et al. Application of nested PCR for diagnosis of histoplasmosis , 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[26] Nina Singh,et al. Donor‐Derived Fungal Infections in Organ Transplant Recipients: Guidelines of the American Society of Transplantation, Infectious Diseases Community of Practice † , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[27] S. Hinrichs,et al. Applying a Real-Time PCR Assay for Histoplasma capsulatum to Clinically Relevant Formalin-Fixed Paraffin-Embedded Human Tissue , 2012, Journal of Clinical Microbiology.
[28] D. Slagle,et al. False‐positive Aspergillus galactomannan assay in solid organ transplant recipients with histoplasmosis , 2012, Transplant infectious disease : an official journal of the Transplantation Society.
[29] J. Oberholzer,et al. A multicenter study of histoplasmosis and blastomycosis after solid organ transplantation , 2012, Transplant infectious disease : an official journal of the Transplantation Society.
[30] L. Wheat,et al. Investigation of the Efficacy of Micafungin in the Treatment of Histoplasmosis Using Two North American Strains of Histoplasma capsulatum , 2011, Antimicrobial Agents and Chemotherapy.
[31] S. A. Marques,et al. Imunologia da paracoccidioidomicose , 2011 .
[32] A. Chakrabarti,et al. Endemic fungal infections in the Asia-Pacific region. , 2011, Medical mycology.
[33] J. Guarner,et al. Histopathologic Diagnosis of Fungal Infections in the 21st Century , 2011, Clinical Microbiology Reviews.
[34] H. Miot,et al. Immunology of paracoccidioidomycosis. , 2011, Anais brasileiros de dermatologia.
[35] E. Dodds-Ashley. Management of Drug and Food Interactions with Azole Antifungal Agents in Transplant Recipients , 2010, Pharmacotherapy.
[36] G. Woods,et al. Clinical and Laboratory Update on Blastomycosis , 2010, Clinical Microbiology Reviews.
[37] Patty W. Wright,et al. Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[38] C. Fontes,et al. Is the geographical origin of a Paracoccidioides brasiliensis isolate important for antigen production for regional diagnosis of paracoccidioidomycosis? , 2010, Mycoses.
[39] I. Boin,et al. Serological profile of pretransplantation liver patients. , 2010, Transplantation proceedings.
[40] D. van Duin,et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[41] C. Oliveira,et al. Phylogenetic analysis of PRP8 intein in Paracoccidioides brasiliensis species complex. , 2008, Fungal genetics and biology : FG & B.
[42] M. Threlkeld,et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[43] L. Travassos,et al. Treatment options for paracoccidioidomycosis and new strategies investigated , 2008, Expert review of anti-infective therapy.
[44] K. Tintelnot,et al. Histoplasmosis in Europe: report on an epidemiological survey from the European Confederation of Medical Mycology Working Group. , 2008, Medical mycology.
[45] D. Andes,et al. Blastomycosis in solid organ transplant recipients , 2007, Transplant infectious disease : an official journal of the Transplantation Society.
[46] F. Queiroz-Telles,et al. An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[47] J. Baddley,et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[48] L. Baddour,et al. Systemic Histoplasmosis: A 15-Year Retrospective Institutional Review of 111 Patients , 2007, Medicine.
[49] L. Wheat,et al. Urine antigen detection of blastomycosis in pediatric patients. , 2006, The Pediatric infectious disease journal.
[50] L. Wheat,et al. Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole. , 2006, The Journal of antimicrobial chemotherapy.
[51] T. Brandhorst,et al. Analysis of non-adhesive pathogenic mechanisms of BAD1 on Blastomyces dermatitidis. , 2006, Medical mycology.
[52] P. Connolly,et al. Antigen Assay with the Potential To Aid in Diagnosis of Blastomycosis , 2004, Journal of Clinical Microbiology.
[53] G. Hessel,et al. Paracoccidioidomycosis in children: clinical presentation, follow-up and outcome. , 2004, Revista do Instituto de Medicina Tropical de Sao Paulo.
[54] C. Yiannoutsos,et al. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[55] A. Peer,et al. The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects , 2004, European Journal of Clinical Pharmacology.
[56] F. Queiroz-Telles,et al. Detection of Circulating gp43 Antigen in Serum, Cerebrospinal Fluid, and Bronchoalveolar Lavage Fluid of Patients with Paracoccidioidomycosis , 2003, Journal of Clinical Microbiology.
[57] Ángela Restrepo,et al. Insuficiencia suprarrenal secundaria a paracoccidioidomicosis , 2002 .
[58] D. Bamberger,et al. Safety and Efficacy of Liposomal Amphotericin B Compared with Conventional Amphotericin B for Induction Therapy of Histoplasmosis in Patients with AIDS , 2002, Annals of Internal Medicine.
[59] U. Prakash,et al. Pulmonary blastomycosis: an appraisal of diagnostic techniques. , 2002, Chest.
[60] Á. Restrepo,et al. [Adrenal gland insufficiency secondary to paracoccidioidomycosis]. , 2002, Biomedica : revista del Instituto Nacional de Salud.
[61] R. Hafner,et al. Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[62] A. Limaye,et al. Transmission of Histoplasma capsulatum by organ transplantation. , 2000, The New England journal of medicine.
[63] C. Taborda,et al. PCR for Diagnosis of Paracoccidioidomycosis , 2000, Journal of Clinical Microbiology.
[64] D. Greenblatt,et al. Effects of the Antifungal Agents on Oxidative Drug Metabolism , 2000, Clinical pharmacokinetics.
[65] D. Bamberger,et al. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[66] B. Guglielmo,et al. Lipid formulations of amphotericin B: clinical efficacy and toxicities. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[67] K. Hendricks,et al. Endemic blastomycosis in Mississippi: epidemiological and clinical studies. , 1997, Seminars in respiratory infections.
[68] M. Saag,et al. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group. , 1997, The American journal of medicine.
[69] G. Campbell,et al. Treatment of blastomycosis with higher doses of fluconazole. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. , 1997, Clinical Infectious Diseases.
[70] P. Connolly,et al. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[71] S. Jaruratanasirikul,et al. Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole , 1997, European Journal of Clinical Pharmacology.
[72] A. Sugar,et al. In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis , 1996, Antimicrobial agents and chemotherapy.
[73] F. Hecht,et al. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group. , 1995, The American journal of medicine.
[74] G. Cloud,et al. Treatment of blastomycosis with fluconazole: a pilot study. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[75] E Brummer,et al. Paracoccidioidomycosis: an update , 1993, Clinical Microbiology Reviews.
[76] L. Levy,et al. Blastomycosis in Africa: clinical features, diagnosis, and treatment. , 1991, Reviews of infectious diseases.
[77] Á. Restrepo,et al. Treatment of paracoccidioidomycosis with itraconazole. , 1990, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[78] Anthony J. Krzysik,et al. Birds in Human Modified Environments and Bird Damage Control: Social, Economic, and Health Implications , 1989 .
[79] W. Ehni,et al. Endogenous reactivation in blastomycosis. , 1989, The American journal of medicine.
[80] J. P. Davis,et al. Two outbreaks of blastomycosis along rivers in Wisconsin. Isolation of Blastomyces dermatitidis from riverbank soil and evidence of its transmission along waterways. , 1987, The American review of respiratory disease.
[81] J. Shenep,et al. Induction of prostaglandin synthesis as the mechanism responsible for the chills and fever produced by infusing amphotericin B. , 1987, The Journal of infectious diseases.
[82] B. Varkey,et al. Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. , 1986, The New England journal of medicine.
[83] L. Wheat,et al. Histoplasmosis in renal allograft recipients. Two large urban outbreaks. , 1983, Archives of internal medicine.
[84] C. Palmer,et al. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. , 1969, The American review of respiratory disease.